Atlas Trials

Pre-approval Single-patient Expanded Access for Elranatamab (PF-06863135)

Clinical trial NCT05238311 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT05238311
Sponsor
Pfizer
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
Multiple Myeloma

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.